SEC Company Response from Accelerate Diagnostics, Inc (AXDX) (CIK 0000727207) — Feb 9, 2022
Accelerate Diagnostics, Inc (AXDX) (CIK 0000727207)
Date: Feb. 9, 2022 · CIK: 0000727207 · Accession: 0001104659-22-017144
AI Filing Summary & Sentiment
File numbers found in text: 333-262494
Letter
Accelerate Diagnostics, Inc.
3950 South Country Club Road, Suite 470
Tucson, Arizona 85714
February 9, 2022
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
Re: Accelerate Diagnostics, Inc.
Registration Statement on Form S-3
File No. 333-262494
Request for Acceleration of Effectiveness
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Accelerate Diagnostics, Inc. (the “Registrant”) hereby requests that the above-referenced Registration Statement be declared effective by the Securities and Exchange Commission at 4:00 p.m., Eastern Time, on Friday, February 11, 2022, or as soon thereafter as practicable.
The Registrant hereby authorizes Daniel M. Mahoney and Joshua Schneiderman, of Snell & Wilmer L.L.P., to orally modify or withdraw this request for acceleration.
[SIGNATURE PAGE FOLLOWS]
Very truly yours,
ACCELERATE DIAGNOSTICS, INC.
Show Raw Text
CORRESP
1
filename1.htm
Accelerate Diagnostics, Inc.
3950 South Country Club Road, Suite 470
Tucson, Arizona 85714
February 9, 2022
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
Re: Accelerate Diagnostics, Inc.
Registration Statement on Form S-3
File No. 333-262494
Request for Acceleration of Effectiveness
Ladies and Gentlemen:
Pursuant to Rule 461 of the General
Rules and Regulations under the Securities Act of 1933, as amended, Accelerate Diagnostics, Inc. (the “Registrant”)
hereby requests that the above-referenced Registration Statement be declared effective by the Securities and Exchange Commission at 4:00
p.m., Eastern Time, on Friday, February 11, 2022, or as soon thereafter as practicable.
The Registrant hereby authorizes Daniel
M. Mahoney and Joshua Schneiderman, of Snell & Wilmer L.L.P., to orally modify or withdraw this request for acceleration.
[SIGNATURE PAGE FOLLOWS]
Very truly yours,
ACCELERATE DIAGNOSTICS, INC.
By:
/s/ Steve Reichling
Name:
Steve Reichling
Title:
Chief Financial Officer
[SIGNATURE PAGE TO REQUEST FOR ACCELERATION]